Par Pharmaceutical, Inc. Receives Final Approval to Market Generic Ultram(R) ER Par to Begin Shipping Tramadol ER Immediately
11/16/2009 8:47:28 AM
More...
|
Par Pharmaceutical, Inc. Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
11/10/2009 8:47:59 AM
More...
|
Par Pharmaceutical, Inc. Reports EPS of $0.76 for Third Quarter 2009 Achieves Record Quarterly Gross Margin of $92 Million
11/6/2009 10:28:51 AM
More...
|
Par Pharmaceutical, Inc. Q3 Profit Beats Estimates on Strong Revenue
11/6/2009 6:32:05 AM
More...
|
Par Pharmaceutical, Inc. to Host Third Quarter 2009 Earnings Conference Call On November 6 at 9:00 am
10/22/2009 11:31:38 AM
More...
|
Par Pharmaceutical, Inc. Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
10/15/2009 8:26:04 AM
More...
|
Biovail Corporation (BVF) Comments on Ultram(R) ER Court Ruling
8/17/2009 9:20:15 AM
More...
|
Par Pharmaceutical, Inc. Wins on Invalidity in Ultram(R) ER Litigation
8/17/2009 6:23:29 AM
More...
|
Par Pharmaceutical, Inc. to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am
7/15/2009 10:07:25 AM
More...
|
Par Pharmaceutical, Inc. Begins Shipment of Generic Miacalcin(R)
6/9/2009 9:02:13 AM
More...
|
|